文献速递前列腺增生与排尿功能障碍

基于远程多日尿动力学检查的男性下尿路症状实用表型分型框架

A Practical Phenotyping Framework for Male Lower Urinary Tract Symptoms Using Remote Multi-day Urinary Diagnostics.
PubMed 文献 · Urology · 2026-03-13

本研究回顾性分析1047例因下尿路症状接受远程多日尿液诊断(RMUD)的男性,中位年龄70岁、中位IPSS 14。通过6个预设指标症状组合定义21种非重叠诊断表型,发现梗阻标准占37.6%、过度活动33.5%、夜尿>2次/晚67.3%、夜间多尿46.8%,多数为混合型而非单纯梗阻。

要点

  • RMUD可同时获取排尿日记、尿流率与IPSS,实现多维度表型分型。
  • 仅37.6%符合梗阻标准,33.5%有过度活动,13.9%为原发性过度活动。
  • 夜尿>2次/晚占67.3%,夜间多尿占46.8%,混合表型常见。

核心结论

  • 基于RMUD的指标症状表型分型揭示男性LUTS存在显著异质性,识别出梗阻、过度活动及夜间多尿等模式。
  • 该框架支持更精准的咨询、治疗选择及识别需进一步评估的患者。

研究设计与样本

  • 回顾性分析1047例因LUTS转诊的男性,在18个中心使用CarePath进行RMUD。
  • RMUD结合多日频率-容量日记、尿流率与IPSS,操作化定义6个指标症状并组合为非重叠诊断表型。

主要发现

  • 中位年龄70岁,中位IPSS 14;2天研究中位排尿15次,92.8%至少产生1次≥150mL的有效排尿。
  • 梗阻标准占37.6%,过度活动占33.5%,原发性/特发性过度活动无梗阻证据占13.9%。
  • 夜尿>2次/晚占67.3%,夜间多尿(ICS NP指数)占46.8%。
  • 6个指标症状组合形成21种离散非重叠诊断表型,多数反映混合性储尿-排尿-夜间多尿表型而非孤立梗阻。

关键数值与推荐

  • 指标症状包括:低流率伴IPSS升高(器械试验标准)、过度活动、原发性过度活动、夜尿、夜间多尿(ICS NP指数)、无合格排尿。

临床怎么用

  • 临床可利用RMUD表型分型对男性LUTS进行更精准的咨询与治疗选择。
  • 识别混合表型有助于避免仅针对梗阻的单一治疗策略,并筛选需进一步评估者。

局限性

  • 回顾性设计,未报告对照组或长期结局。
  • 样本来自转诊中心,外推性需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To describe the distribution of predefined Index Symptoms and Diagnostic Profiles in a cohort of men undergoing Remote multi-day urinary diagnostics (RMUD) for lower urinary tract symptoms (LUTS). METHODS: We retrospectively analyzed 1047 RMUD performed with CarePath in men referred for LUTS across 18 sites. RMUD combined multi-day frequency-volume and uroflowmetry data with the IPSS. Six Index Symptoms were operationalized as follows: (1) low flow with elevated IPSS (device trial criteria), (2) overactivity, (3) primary overactivity (overactivity without obstructive RMUD findings), (4) nocturia, (5) nocturnal polyuria (NP) using the ICS NP index, and 6) no qualifying voids. Combinations of the Index Symptoms were used to define non-overlapping Diagnostic Profiles. RESULTS: Median age was 70 years and median IPSS was 14. Patients produced a median of 15 voids across a 2-day study and 92.8% produced at least 1 qualifying void ≥150mL. Obstructive criteria were met in 37.6% of men, while 33.5% demonstrated overactivity and 13.9% had primary/idiopathic overactivity without RMUD evidence of obstruction. Nocturia >2 per night occurred in 67.3%, and NP in 46.8% of patients. Across the cohort, the 6 Index Symptoms combined into 21 discrete, non-overlapping Diagnostic Profiles, most of which reflected mixed storage-voiding-NP phenotypes rather than isolated obstruction. CONCLUSION: RMUD-enabled phenotyping with Index Symptoms reveals substantial heterogeneity among men with LUTS and identifies patterns of obstruction, overactivity, and NP. This LUTS phenotyping framework supports more precise counseling, treatment selection, and identification of patients who warrant further evaluation.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Watts J, Godelfer D, Knoedler J, et al. A Practical Phenotyping Framework for Male Lower Urinary Tract Symptoms Using Remote Multi-day Urinary Diagnostics. Urology. 2026. PMID: 41831697. doi:10.1016/j.urology.2026.03.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。